These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 21276817)

  • 21. Analyzing dendritic spine pathology in Alzheimer's disease: problems and opportunities.
    Dorostkar MM; Zou C; Blazquez-Llorca L; Herms J
    Acta Neuropathol; 2015 Jul; 130(1):1-19. PubMed ID: 26063233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease.
    Lacor PN; Buniel MC; Furlow PW; Clemente AS; Velasco PT; Wood M; Viola KL; Klein WL
    J Neurosci; 2007 Jan; 27(4):796-807. PubMed ID: 17251419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synaptic Actin Dysregulation, a Convergent Mechanism of Mental Disorders?
    Yan Z; Kim E; Datta D; Lewis DA; Soderling SH
    J Neurosci; 2016 Nov; 36(45):11411-11417. PubMed ID: 27911743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spines, plasticity, and cognition in Alzheimer's model mice.
    Spires-Jones T; Knafo S
    Neural Plast; 2012; 2012():319836. PubMed ID: 22203915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synaptic Plasticity, Dementia and Alzheimer Disease.
    Skaper SD; Facci L; Zusso M; Giusti P
    CNS Neurol Disord Drug Targets; 2017; 16(3):220-233. PubMed ID: 28088900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer's disease.
    Baglietto-Vargas D; Prieto GA; Limon A; Forner S; Rodriguez-Ortiz CJ; Ikemura K; Ager RR; Medeiros R; Trujillo-Estrada L; Martini AC; Kitazawa M; Davila JC; Cotman CW; Gutierrez A; LaFerla FM
    Aging Cell; 2018 Aug; 17(4):e12791. PubMed ID: 29877034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer's disease.
    Bai Y; Li M; Zhou Y; Ma L; Qiao Q; Hu W; Li W; Wills ZP; Gan WB
    Mol Neurodegener; 2017 Nov; 12(1):86. PubMed ID: 29137651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for altered dendritic spine compartmentalization in Alzheimer's disease and functional effects in a mouse model.
    Androuin A; Potier B; Nägerl UV; Cattaert D; Danglot L; Thierry M; Youssef I; Triller A; Duyckaerts C; El Hachimi KH; Dutar P; Delatour B; Marty S
    Acta Neuropathol; 2018 Jun; 135(6):839-854. PubMed ID: 29696365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoxetine delays the cognitive function decline and synaptic changes in a transgenic mouse model of early Alzheimer's disease.
    Zhou CN; Chao FL; Zhang Y; Jiang L; Zhang L; Fan JH; Wu YX; Dou XY; Tang Y
    J Comp Neurol; 2019 Jun; 527(8):1378-1387. PubMed ID: 30592045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic Microtubules in Alzheimer's Disease: Association with Dendritic Spine Pathology.
    Pchitskaya EI; Zhemkov VA; Bezprozvanny IB
    Biochemistry (Mosc); 2018 Sep; 83(9):1068-1074. PubMed ID: 30472945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior.
    Selkoe DJ
    Behav Brain Res; 2008 Sep; 192(1):106-13. PubMed ID: 18359102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synaptic actin stabilization protein loss in Down syndrome and Alzheimer disease.
    Lauterborn JC; Cox CD; Chan SW; Vanderklish PW; Lynch G; Gall CM
    Brain Pathol; 2020 Mar; 30(2):319-331. PubMed ID: 31410926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Layer-specific alterations to CA1 dendritic spines in a mouse model of Alzheimer's disease.
    Merino-Serrais P; Knafo S; Alonso-Nanclares L; Fernaud-Espinosa I; DeFelipe J
    Hippocampus; 2011 Oct; 21(10):1037-44. PubMed ID: 20848609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiamine deficiency contributes to synapse and neural circuit defects.
    Yu Q; Liu H; Sang S; Chen L; Zhao Y; Wang Y; Zhong C
    Biol Res; 2018 Sep; 51(1):35. PubMed ID: 30231926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential role of rho GTPases in Alzheimer's disease pathogenesis.
    Bolognin S; Lorenzetto E; Diana G; Buffelli M
    Mol Neurobiol; 2014 Oct; 50(2):406-22. PubMed ID: 24452387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease.
    Chabrier MA; Cheng D; Castello NA; Green KN; LaFerla FM
    Neurobiol Dis; 2014 Apr; 64():107-17. PubMed ID: 24440055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
    Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM
    J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.
    Pereira C; Agostinho P; Moreira PI; Cardoso SM; Oliveira CR
    Curr Drug Targets CNS Neurol Disord; 2005 Aug; 4(4):383-403. PubMed ID: 16101556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dendritic spines are lost in clusters in Alzheimer's disease.
    Mijalkov M; Volpe G; Fernaud-Espinosa I; DeFelipe J; Pereira JB; Merino-Serrais P
    Sci Rep; 2021 Jun; 11(1):12350. PubMed ID: 34117272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organization and dynamics of the actin cytoskeleton during dendritic spine morphological remodeling.
    Chazeau A; Giannone G
    Cell Mol Life Sci; 2016 Aug; 73(16):3053-73. PubMed ID: 27105623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.